Search Results for: coronavirus
Skip to results
509 results
- Health & Medicine
How antibodies may cause rare blood clots after some COVID-19 vaccines
Vaccine-induced antibodies attach to a specific spot on a protein involved in clot formation, a study suggests.
- Health & Medicine
How relocating musicians can reduce COVID-19 risk at concerts
Based on simulations of how air flows across a stage, the Utah Symphony rearranged where its musicians sit and boosted ventilation.
- Health & Medicine
What experts know so far about the delta variant
The variant, which first emerged in India, is outcompeting other highly transmissible forms of the coronavirus as it spreads around the world.
- Health & Medicine
Experts predict U.S. COVID-19 cases will dip in summer but surge in winter
Masks, vaccines and coronavirus variants could all affect how bad a predicted winter surge gets.
- Science & Society
What will life be like after the coronavirus pandemic ends?
Researchers offer a range of perspectives on the possible long-term social consequences of COVID-19.
- Health & Medicine
A year ago, we asked 6 questions about COVID-19. Here’s how the answers evolved
A year after launching our Coronavirus Update newsletter, we revisit the first topics we wrote about.
- Health & Medicine
The U.K. approved the world’s first COVID-19 human challenge trial
Dozens of young, healthy volunteers will be deliberately exposed to the coronavirus to find out how much virus it takes to get someone sick.
- Health & Medicine
Here’s what makes 4 promising COVID-19 vaccines unique — and potentially useful
More vaccines still in the works are exploring a variety of approaches, including pills and electrical zaps.
- Health & Medicine
Louis Pasteur’s devotion to truth transformed what we know about health and disease
Two centuries after his birth, Louis Pasteur's work on pasteurization, germ theory and vaccines is as relevant as ever.
- Health & Medicine
How coronavirus variants may drive reinfection and shape vaccination efforts
New coronavirus variants could infect people who have already recovered from COVID-19 or been vaccinated, but there are still many unknowns.
- Health & Medicine
AstraZeneca’s COVID-19 vaccine holds up in an updated analysis of trial data
The redo dropped the overall efficacy of AstraZeneca’s vaccine from 79 percent to 76 percent. But a slight fluctuation is not unexpected, experts say.
-
Living with pandemic uncertainty, Year 2
Editor in chief Nancy Shute looks back at a year of COVID-19 coverage and living with the pandemic.
